A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)

Peer Review reports

Original Submission
29 Oct 2023	Submitted	Original manuscript
7 Jan 2024	Reviewed	Reviewer Report - Shriya Das
9 Jan 2024	Reviewed	Reviewer Report - Yang Chen
15 Jan 2024	Reviewed	Reviewer Report - Muslim Syed
21 Jan 2024	Reviewed	Reviewer Report - Milind Bhagat
29 Jan 2024	Reviewed	Reviewer Report - Manan Karki
25 Feb 2024	Author responded	Author comments - Naeemeh Dini
Resubmission - Version 2
25 Feb 2024	Submitted	Manuscript version 2
28 Feb 2024	Reviewed	Reviewer Report - Yang Chen
29 Feb 2024	Reviewed	Reviewer Report - Shriya Das
9 Mar 2024	Reviewed	Reviewer Report - Milind Bhagat
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
11 Mar 2024	Editorially accepted
6 Apr 2024	Article published	10.1186/s13063-024-08051-7

Back to article page